ANTIHYPERTENSIVE AND LIPID LOWERING TREATMENT TO PREVENT HEART ATTACK

抗高血压和降脂治疗预防心脏病

• 批准号: 6218487
• 负责人: GEORGE W. VETROVEC
• 金额: $ 0.06万
• 依托单位: VIRGINIA COMMONWEALTH UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6218487
• 关键词: ACE inhibitors; alpha adrenergic agent; antihypertensive agents; calcium channel blockers; cardiovascular disorder prevention; clinical research; clinical trials; coronary disorder; diuretics; heart disorder chemotherapy; human mortality; human subject; human therapy evaluation; lipogenesis inhibitor; myocardial infarction; outcomes research

To determine whether the combined incidence of fatal coronary heart disease and non-fatal myocardial infarction differs between diuretic treatment and three alternative antiypertensive pharmacologic treatments--a calcium antagonist, an ACE inhibitor and an alpha adrenergic blocker.

为了确定致命性冠心病和非致命性心肌梗死的合并发病率在利尿剂治疗和三种替代的抗血压药物治疗--钙拮抗剂、血管紧张素转换酶抑制剂和α-肾上腺素能阻滞剂--之间是否存在差异。